Top

Published in:

01-04-2021 | Insulins | Original Article

The diabetes quality of life brief clinical inventory in combination with the management strategies in type 1 diabetes mellitus with or without the use of insulin pump

Authors: Emmanouil S. Benioudakis, Evangelos D. Georgiou, Eirini D. Barouxi, Athanasios M. Armagos, Vaia Koutsoumani, Faidra Anastasiou-Veneti, Eleni Koutsoumani, Maria Brokalaki

Published in: Diabetology International | Issue 2/2021

Abstract

Aims

The aims of this study are to evaluate any differences in the Quality of life among Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Dose Injection (MDI) insulin delivery, applying the Diabetes Quality of life Brief Clinical Inventory (DQoL-BCI) questionnaire, and assess the diabetes management strategies between the two groups.

Methods

One hundred and ten adult participants (male/female ratio 1:2.7) with type 1 diabetes were recruited in this online survey. Forty-eight of them were using CSII and the rest 62 (were using) MDI insulin delivery. A 23-item socio-demographic/diabetes management strategies questionnaire and the 15-item DQoL-BCI were administered.

Results

CSII users scored statistically, significantly better at the satisfaction treatment subscale (p = 0.032) of the DQoL-BCI and emerged that they were implemented more management strategies such as dietician guidance services (p = 0.002), carbohydrate education seminars (p = 0.03). Predictive factors were also detected regarding the HbA_1c < 7% (53 mmol/mol) and β-coefficients in relation to DQoL-BCI questionnaire with the subscales of a negative impact and satisfaction treatment.

Conclusion

Diabetes self-management education plays a key role to a better compliance with the treatment. Client-centered multidisciplinary centers in T1DM education are essential so that they be applicable for all T1DM patients irrespective of the type of insulin delivery they used.

International Diabetes Federation. IDF diabetes atlas. 9th ed. Brussels: International Diabetes Federation; 2019.

American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care. 2020a;43:S14–31. https://doi.org/10.2337/dc20-S002.CrossRef

Taleb N, Messier V, Ott-Braschi S, Ardilouze LJ, Rabasa-Lhoret R. Perceptions and experiences of adult patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: results of an online survey. Diabetes Res Clin Pract. 2018;144:42–50. https://doi.org/10.1016/j.diabres.2018.07.035.CrossRefPubMed

Sora DN, Shashpal F, Bond AE, Jenkins JA. Insulin pumps: review of technological advancement in diabetes management. Am J Med Sci. 2019;358:326–31. https://doi.org/10.1016/j.amjms.2019.08.008.CrossRefPubMed

Home DP. Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes? Diabetes Obes Metab. 2015;17:1011–20. https://doi.org/10.1111/dom.12501.CrossRefPubMedPubMedCentral

The DCCT/EDIC Research Group. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT/EDIC Study 30-year follow-up. Diabetes Care. 2016;39:686–93. https://doi.org/10.2337/dc15-1990.CrossRef

Allen N, Gupta A. Current diabetes technology: striving for the artificial pancreas. Diagnostics. 2019;9:1–16. https://doi.org/10.3390/diagnostics9010031.CrossRef

Mian Z, Hermayer KL, Jenkins A. Continuous glucose monitoring: review of an innovation in diabetes management. Am J Med Sci. 2019;358:332–9. https://doi.org/10.1016/j.amjms.2019.07.003.CrossRefPubMed

Krzymien J, Rachuta M, Kozlowska I, Ladyzynski P, Foltynski P. Treatment of patients with type 1 diabetes—insulin pumps or multiple injections? Biocybern Biomed Eng. 2016;36:1–8. https://doi.org/10.1016/j.bbe.2015.10.002.CrossRef

10.

Franciosi M, Maione A, Pomili B, Amoretti R, Busetto E, Capani F, et al. Correlates of quality of life in adults with type 1 diabetes treated with continuous subcutaneous insulin injection. Nutr Metab Cardiovasc Dis. 2010;20:7–14. https://doi.org/10.1016/j.numecd.2009.02.012.CrossRefPubMed

11.

DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ. 2002;325:746. https://doi.org/10.1136/bmj.325.7360.366/c.CrossRefPubMedCentral

12.

American Diabetes Association. Promoting health and reducing disparities in populations. Diabetes Care. 2017;40:S6–10. https://doi.org/10.2337/dc17-S002.CrossRef

13.

American Diabetes Association. Facilitating behavior change and well-being to improve health outcomes: standards of medical care in Diabetes-2020. Diabetes Care. 2020b;43:S48–65. https://doi.org/10.2337/dc20-S005.CrossRef

14.

Schmitt A, Gahr A, Hermanns N, Kulzer B, Huber J, Haak T. The Diabetes Self-Management Questionnaire (DSMQ): development and evaluation of an instrument to assess diabetes self-care activities associated with glycaemic control. Health Qual Life Outcomes. 2013;11:138. https://doi.org/10.1186/1477-7525-11-138.CrossRefPubMedPubMedCentral

15.

Beck J, Greenwood AD, Blanton L, Bollinger TS, Butcher KM, Condon EJ. 2017 national standards for diabetes self-management education and support. Diabetes Care. 2017;40:1409–19. https://doi.org/10.2337/dci17-0025.CrossRefPubMed

16.

Rekleiti M, Souliotis K, Sarafis P, Tsironi M, Kyriazis I. Measuring the reliability and validity of the Greek edition of the diabetes quality of life brief clinical inventory. Diabetes Res Clin Pract. 2018;140:61–71. https://doi.org/10.1016/j.diabres.2018.01.019.

17.

Burroughs ET, Desikan R, Waterman MB, Gilin D, McGill J. Development and validation of the diabetes quality of life brief clinical inventory. Diabetes Spectrum. 2004;17:41–59. https://doi.org/10.2337/diaspect.17.1.41.CrossRef

18.

Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175–91. https://doi.org/10.3758/BF03193146.CrossRef

19.

Munka KJ, Linda SB, Jørgensen LH. Change in HbA1c concentration as decision parameter for frequency of HbA_1c measurement. Scand J Clin Lab Invest. 2019;79:320–4. https://doi.org/10.1080/00365513.2019.1622032.CrossRef

20.

American Diabetes Association. Glycemic targets: standards of medical care in diabetes-2020. Diabetes Care. 2020c;43:S66–76. https://doi.org/10.2337/dc20-S006.CrossRef

21.

Turton LJ, Raab R, Rooney BK. Low-carbohydrate diets for type 1 diabetes mellitus: a systematic review. PLoS ONE. 2018;13(3):e0194987. https://doi.org/10.1371/journal.pone.0194987.CrossRefPubMedPubMedCentral

22.

Franz MJ, Powers MA, Leontos C, Holzmeister LA, Kulkarni K, Monk A, et al. The evidence for medical nutrition therapy for type 1 and type 2 diabetes in adults. J Am Dietetic Assoc. 2010;110:1852–89. https://doi.org/10.1016/j.jada.2010.09.014.CrossRef

23.

Lauria A, Barker A, Schloot N, Hosszufalusi N, Ludvigsson J, Mathieu C, et al. BMI is an important driver of b-cell loss in type 1 diabetes upon diagnosis in 10 to 18-year-old children. Eur J Endocrinol. 2015;172:107–13. https://doi.org/10.1530/EJE-14-0522.CrossRefPubMed

24.

Claussen A, Møller BJ, Kristensen RN, Klim S, Kjellsson CM, Ingwersen HS, et al. Impact of demographics and disease progression on the relationship between glucose and HbA1c. Eur J Pharm Sci. 2017;114:417–23. https://doi.org/10.1016/j.ejps.2017.04.006.CrossRef

25.

Svedbo Engström M, Leksell J, Johansson U, Borg S, Palaszewski B, Franzén S, et al. Health-related quality of life and glycaemic control among adults with type 1 and type 2 diabetes—a nationwide cross-sectional study. Health Qual Life Outcomes. 2019;17:141. https://doi.org/10.1186/s12955-019-1212-z.CrossRefPubMedPubMedCentral

26.

Al-Taie N, Maftei D, Kautzky-Willer A, Krebs M, Stingl H. Assessing the quality of life among patients with diabetes in Austria and the correlation between glycemic control and the quality of life. Primary Care Diabetes. 2020;14:133–8. https://doi.org/10.1016/j.pcd.2019.11.003.CrossRefPubMed

27.

Hsu H-C, Lee Y-J, Wang R-H. Influencing pathways to quality of life and HbA1c in patients with diabetes: a longitudinal study that inform evidence-based practice. Worldviews Evid Based Nurs. 2018;15:104–12. https://doi.org/10.1111/wvn.12275.CrossRefPubMed

28.

Anderson BJ, Laffel LM, Domenger C, Danne T, Phillip M, Mazza C, et al. Factors associated with diabetes-specific health-related quality of life in youth with type 1 diabetes: the global teens study. Diabetes Care. 2017;40:1002–9. https://doi.org/10.2337/dc16-1990.CrossRefPubMedPubMedCentral

29.

Sadarangani KP, Von Oetinger A, Soto Isla N, Martínez-Gómez D. Leisure time physical activity is associated with better metabolic control in adults with type 1 and type 2 diabetes mellitus: a cross-sectional study from two public hospitals in Chile. Primary Care Diabetes. 2019;13:360–9. https://doi.org/10.1016/j.pcd.2019.01.009.CrossRefPubMed

30.

Riddell MC, Gallen IW, Smart CE, Taplin CE, Adolfsson P, Lumb AN, et al. Exercise management in type 1 diabetes: a consensus statement. Lancet Diabetes Endocrinol. 2017;5:377–90. https://doi.org/10.1016/S2213-8587(17)30014-1.CrossRefPubMed

31.

Gagliardino JJ, Chantelot J-M, Domenger C, Ilkova H, Ramachandran A, Kaddaha G, et al. Diabetes education and health insurance: how they affect the quality of care provided to people with type 1 diabetes in Latin America. Data from the International Diabetes Mellitus Practices Study (IDMPS). Diabetes Res Clin Pract. 2019;147:47–54. https://doi.org/10.1016/j.diabres.2018.08.007.CrossRefPubMed

32.

Vincent C, Hall P, Ebsary S, Hannay S, Hayes-Cardinal L, Husein N. Knowledge confidence and desire for further diabetes-management education among nurses and personal support workers in long-term care. Can J Diabetes. 2016;40:226–33. https://doi.org/10.1016/j.jcjd.2015.11.001.CrossRefPubMed

33.

Humayun MA, Jenkins E, Knott J, Ryder J, Shaban C, Weiss M, et al. Intensive structured education for type 1 diabetes management using BERTIE: long-term follow-up to assess impact on glycaemic control and quality of life indices. Diabetes Res Clin Pract. 2018;143:275–81. https://doi.org/10.1016/j.-diabres.2018.07.034.CrossRefPubMed

34.

Vyas C, Dalal L, Talaviya P, Saboo B. Multiple educational programs improves glycemic control, quality of life with diminishing the impact of diabetes in poorly controlled type 1 diabetics. Diabetes Metab Syndr Clin Res Rev. 2017;11(2):S601–6. https://doi.org/10.1016/j.dsx.2017.04.011.CrossRef

35.

Bisanz K, Parker A, Byrne C, Parker AS, Thomas J, Mancino J, et al. Identification of generalist registered dietitian nutritionist knowledge gaps in diabetes medical nutrition therapy compared to diabetes-credentialed registered dietitian nutritionists: results of a survey to inform educational opportunities. J Acad Nutr Diet. 2018;118(7):1312–21. https://doi.org/10.1016/j.jand.2018.01.009.CrossRefPubMed

36.

Marincic PZ, Salazar MV, Hardin A, Scott S, Fan SX, Gaillard PR, et al. Diabetes self-management education and medical nutrition therapy: a multisite study documenting the efficacy of registered dietitian nutritionist interventions in the management of glycemic control and diabetic dyslipidemia through retrospective chart review. J Acad Nutr Diet. 2019;119(3):449–63. https://doi.org/10.1016/j.jand.2018.06.303.CrossRefPubMed

37.

Razaz JM, Rahmani J, Varkaneh HK, Thompson J, Clark C, Abdulazeem HM. The health effects of medical nutrition therapy by dietitians in patients with diabetes: a systematic review and meta-analysis. Primary Care Diabetes. 2019;13(5):P399-408. https://doi.org/10.1016/j.pcd.2019.05.001.CrossRef

38.

Hamdy O, Barakatun-Nisak MY. Nutrition in diabetes. Endocrinol Metab Clin N Am. 2016;45(4):799–817. https://doi.org/10.1016/j.ecl.2016.06.010.CrossRef

39.

Wu J, Davis-Ajami ML, Lu KZ. Real-world impact of ongoing regular exercise in overweight and obese US adults with diabetes on health care utilization and expenses. Primary Care Diabetes. 2019;13:430–40. https://doi.org/10.1016/j.pcd.2019.02.003.CrossRefPubMed

40.

Tonoli C, Heyman E, Roelands B, Buyse L, Cheung SS, Berthoin S, Meeusen R. Effects of different types of acute and chronic (training) exercise on glycaemic control in type 1 diabetes mellitus: a meta-analysis. Sports Medicine. 2012;42:1059–80. https://doi.org/10.1007/BF03262312.CrossRefPubMed

41.

Skinner TC, Carey ME, Cradock S, Daly H, Davies MJ, Doherty Y, et al. Diabetes education and self-management for ongoing and newly diagnosed (DESMOND): process modelling of pilot study. Patient Educ Couns. 2006;64(1–3):369–77. https://doi.org/10.1016/j.pec.2006.04.007.CrossRefPubMed

42.

Pouwer F, Hermanns N. Insulin therapy and quality of life. A review. Diabetes/Metab Res Rev. 2009;25(1):S4–10. https://doi.org/10.1002/dmrr.981.CrossRef

43.

Renard E. Insulin pump use in Europe. Diabetes Technol Ther. 2010;12(1):S29–32. https://doi.org/10.1089/dia.2009.0189.CrossRefPubMed

44.

Peyrot M, Skovlund SE, Landgraf R. Epidemiology and correlates of weight worry in the multinational diabetes attitudes, wishes, and needs study. Curr Med Res Opin. 2009;25(8):1985–93. https://doi.org/10.1185/03007990903073654.CrossRefPubMed

45.

Quirós C, Viñals C, Giménez M, Roca D, Conget I. Assessment of the effectiveness of long-term insulin pump therapy using a combined goal of HbA1c decrease and absence of severe hypoglycemia. Endocrinología, Diabetes y Nutrición. 2019;66:534–9. https://doi.org/10.1016/j.endien.2019.03.013.CrossRefPubMed

46.

Peters JC, Hindmarsh CP, Thompson JR. Insulin pump therapy. Paediatr Child Health. 2017;27:160–5. https://doi.org/10.1016/j.paed.2017.02.002.CrossRef

47.

Bergis D, Ehrmann D, Albrecht C, Haak T, Kulzer B, Hermanns N. Comparison of the efficacy of an education program for people with diabetes and insulin pump treatment (INPUT) in a randomized controlled trial setting and the effectiveness in a routine care setting: results of a comparative effectiveness study. Patient Educ Couns. 2019;102:1868–74. https://doi.org/10.1016/j.pec.2019.04.021.CrossRefPubMed

48.

The Constitution of Greece [Greece]. 2018. https://bit.ly/2RV0d9B. Accessed 15 June 2020.

49.

Sumnik Z, Szypowska A, Iotova V, Bratina N, Cherubini V, Forsander G, et al. Persistent heterogeneity in diabetes technology reimbursement for children with type 1 diabetes: the SWEET perspective. Pediatr Diabetes. 2019;20:434–43. https://doi.org/10.1111/pedi.12833.CrossRefPubMed

50.

Nichols J, Boutette S, Banasiak K. Lived experience as a distinct information source: a case study to improve e-health products for adults with type 1 or 2 diabetes starting insulin. Can J Diabetes. 2018;42(442–445):e1. https://doi.org/10.1016/j.jcjd.2017.10.057.CrossRef

51.

American Diabetes Association. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes-2020. Diabetes Care. 2020d;43:S37–47. https://doi.org/10.2337/dc20-S004.CrossRef

52.

Somali M, Paschou SA, Mouslech Z. Insulin pumps use in Greece: efficacy and safety data from 140 patients with type 1 diabetes mellitus. Diabetes Res Clin Pract. 2020. https://doi.org/10.1016/j.diabres.2020.108026.CrossRefPubMed

Title: The diabetes quality of life brief clinical inventory in combination with the management strategies in type 1 diabetes mellitus with or without the use of insulin pump
Authors: Emmanouil S. Benioudakis
Evangelos D. Georgiou
Eirini D. Barouxi
Athanasios M. Armagos
Vaia Koutsoumani
Faidra Anastasiou-Veneti
Eleni Koutsoumani
Maria Brokalaki
Publication date: 01-04-2021
Publisher: Springer Singapore
Keywords: Insulins
Diabetes
Insulins
Type 1 Diabetes
Published in: Diabetology International / Issue 2/2021
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI: https://doi.org/10.1007/s13340-020-00477-z

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Aims

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2021

Behavioral changes in patients with diabetes during the COVID-19 pandemic

Impact of dietary counseling on the perception of diet in patients with gestational diabetes mellitus

Protective effect of pregabalin on the brain tissue of diabetic rats

Case of slowly progressive type 1 diabetes mellitus with drastically reduced insulin secretory capacity after immune checkpoint inhibitor treatment for advanced renal cell carcinoma

A review of the current evidence on the sensitivity and specificity of the Ipswich touch test for the screening of loss of protective sensation in patients with diabetes mellitus

Hereditary spherocytosis diagnosed with extremely low glycated hemoglobin compared to plasma glucose levels

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage